A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Stimulants
This training is a guide for addiction care teams caring for people who use stimulants, including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants and discuss the practical implementation of evidence-based treatment for patients who use stimulants, with a concentration on outpatient treatment settings.
![]() |
Monday, 8/3/2026 1:00 pm – 4:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Addiction 101
This training will provide foundational knowledge on addiction as a chronic medical condition, as well as an overview of evidence-based interventions, including medications for addiction treatment (MAT).
![]() |
Tuesday, 8/4/2026 12:00 pm – 1:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians |
Topic: Alcohol
This training is designed to provide an introductory overview of alcohol use disorders. We will explore the latest epidemiological data, with a focus on the prevalence and trends of alcohol use and alcohol use disorders in the United States. Diagnostic criteria and screening tools to assess for alcohol use disorders will be discussed. Additionally, we will examine evidence-based interventions to treat alcohol use disorders and support individuals in their recovery.
![]() |
Monday, 8/10/2026 10:00 am – 11:00 am ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Alcohol
Many individuals experiencing mild alcohol withdrawal syndrome can be safely and successfully managed in the outpatient setting, allowing less interruption to one’s professional, family, and social obligations. This training will provide an overview of alcohol withdrawal assessment and management in an outpatient setting. Participants will be able to identify the signs and symptoms of alcohol withdrawal and appropriate candidates for outpatient withdrawal management. Validated tools to assess alcohol withdrawal will be reviewed and evidence-based medication management for outpatient alcohol withdrawal will be discussed.
![]() |
Tuesday, 8/11/2026 3:00 pm – 4:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Stimulants
This training provides an introduction to stimulant use disorder, including evidence-informed treatments and interventions.
![]() |
Thursday, 8/20/2026 12:00 pm – 1:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.
![]() |
Tuesday, 9/15/2026 3:00 pm – 4:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: Addiction 101
This training will provide foundational knowledge on addiction as a chronic medical condition, as well as an overview of evidence-based interventions, including medications for addiction treatment (MAT).
![]() |
Friday, 9/18/2026 2:00 pm – 3:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians |
Topic: Buprenorphine
This training provides healthcare providers with advanced knowledge and practical skills to deliver high-quality, patient-centered treatment plans for individuals on buprenorphine for opioid use disorder (OUD). Participants will enhance their confidence in buprenorphine initiation through real-world case studies, exploring low-barrier models of care to improve access for individuals with OUD and strategies to reduce the risk of precipitated withdrawal.
![]() |
Tuesday, 10/13/2026 2:00 pm – 4:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: Stimulants
This training is a guide for addiction care teams caring for people who use stimulants, including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants and discuss the practical implementation of evidence-based treatment for patients who use stimulants, with a concentration on outpatient treatment settings.
![]() |
Wednesday, 10/14/2026 9:00 am – 12:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Alcohol
Many individuals experiencing mild alcohol withdrawal syndrome can be safely and successfully managed in the outpatient setting, allowing less interruption to one’s professional, family, and social obligations. This training will provide an overview of alcohol withdrawal assessment and management in an outpatient setting. Participants will be able to identify the signs and symptoms of alcohol withdrawal and appropriate candidates for outpatient withdrawal management. Validated tools to assess alcohol withdrawal will be reviewed and evidence-based medication management for outpatient alcohol withdrawal will be discussed.
![]() |
Friday, 10/16/2026 12:00 pm – 1:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |